Novartis (NVS) Reports In-Line Q3 EPS of $1.21; Guides FY15 Sales Growth

Go back to Novartis (NVS) Reports In-Line Q3 EPS of $1.21; Guides FY15 Sales Growth

Form 6-K NOVARTIS AG For: Dec 31

January 27, 2015 7:43 AM EST

SECURITIES AND EXCHANGE COMMISSION Washington, D.C.... More